

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 5.38233956 |
| 2 | protein localization to endosome (GO:0036010) | 4.87632146 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.54334125 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 4.54334125 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.15353447 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 4.15353447 |
| 7 | cysteine metabolic process (GO:0006534) | 4.08646869 |
| 8 | B cell receptor signaling pathway (GO:0050853) | 3.88683162 |
| 9 | regulation of water loss via skin (GO:0033561) | 3.83558659 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 3.79947370 |
| 11 | establishment of skin barrier (GO:0061436) | 3.76109212 |
| 12 | oligosaccharide catabolic process (GO:0009313) | 3.75315553 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 3.74796738 |
| 14 | fatty acid elongation (GO:0030497) | 3.73809458 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.62241461 |
| 16 | drug transmembrane transport (GO:0006855) | 3.59846185 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.52415007 |
| 18 | protein carboxylation (GO:0018214) | 3.52415007 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.48252418 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.48252418 |
| 21 | bile acid biosynthetic process (GO:0006699) | 3.41021795 |
| 22 | valine metabolic process (GO:0006573) | 3.38845618 |
| 23 | complement activation, alternative pathway (GO:0006957) | 3.37751808 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.33284894 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.32746330 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 3.32326752 |
| 27 | phospholipid efflux (GO:0033700) | 3.29885213 |
| 28 | response to phenylpropanoid (GO:0080184) | 3.26113603 |
| 29 | regulation of phospholipase A2 activity (GO:0032429) | 3.21758635 |
| 30 | ethanol metabolic process (GO:0006067) | 3.19081872 |
| 31 | cellular modified amino acid catabolic process (GO:0042219) | 3.18066743 |
| 32 | urate metabolic process (GO:0046415) | 3.17658616 |
| 33 | very long-chain fatty acid metabolic process (GO:0000038) | 3.16748803 |
| 34 | iron ion import (GO:0097286) | 3.16471617 |
| 35 | glyoxylate metabolic process (GO:0046487) | 3.13701325 |
| 36 | tryptophan catabolic process (GO:0006569) | 3.11903529 |
| 37 | indole-containing compound catabolic process (GO:0042436) | 3.11903529 |
| 38 | indolalkylamine catabolic process (GO:0046218) | 3.11903529 |
| 39 | tryptophan metabolic process (GO:0006568) | 3.11785242 |
| 40 | kynurenine metabolic process (GO:0070189) | 3.10677985 |
| 41 | regulation of protein activation cascade (GO:2000257) | 3.09960240 |
| 42 | hormone catabolic process (GO:0042447) | 3.09757819 |
| 43 | lysine catabolic process (GO:0006554) | 3.09464627 |
| 44 | lysine metabolic process (GO:0006553) | 3.09464627 |
| 45 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.08416428 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08232179 |
| 47 | germinal center formation (GO:0002467) | 3.07717995 |
| 48 | serine family amino acid catabolic process (GO:0009071) | 3.06566216 |
| 49 | high-density lipoprotein particle remodeling (GO:0034375) | 3.04768108 |
| 50 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.03705793 |
| 51 | embryonic process involved in female pregnancy (GO:0060136) | 3.03356596 |
| 52 | Rap protein signal transduction (GO:0032486) | 3.01864304 |
| 53 | regulation of complement activation (GO:0030449) | 3.01863188 |
| 54 | urea cycle (GO:0000050) | 3.01410547 |
| 55 | urea metabolic process (GO:0019627) | 3.01410547 |
| 56 | cell adhesion mediated by integrin (GO:0033627) | 2.99722819 |
| 57 | homocysteine metabolic process (GO:0050667) | 2.99565537 |
| 58 | * sphingoid metabolic process (GO:0046519) | 2.97052298 |
| 59 | sphingomyelin metabolic process (GO:0006684) | 2.95271871 |
| 60 | B cell proliferation (GO:0042100) | 2.93989830 |
| 61 | response to laminar fluid shear stress (GO:0034616) | 2.92715322 |
| 62 | activation of Rac GTPase activity (GO:0032863) | 2.91349914 |
| 63 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.90858632 |
| 64 | short-chain fatty acid metabolic process (GO:0046459) | 2.90855489 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 2.88862600 |
| 66 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.87349545 |
| 67 | regulation of early endosome to late endosome transport (GO:2000641) | 2.87059598 |
| 68 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.86905145 |
| 69 | multicellular organismal water homeostasis (GO:0050891) | 2.86823612 |
| 70 | regulation of triglyceride catabolic process (GO:0010896) | 2.86308641 |
| 71 | nuclear pore complex assembly (GO:0051292) | 2.86178782 |
| 72 | bile acid metabolic process (GO:0008206) | 2.86109469 |
| 73 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.85736621 |
| 74 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.85027661 |
| 75 | NIK/NF-kappaB signaling (GO:0038061) | 2.84938129 |
| 76 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.84222455 |
| 77 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.83614593 |
| 78 | cell-substrate junction assembly (GO:0007044) | 2.80917969 |
| 79 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.79933380 |
| 80 | negative regulation of lipase activity (GO:0060192) | 2.79752100 |
| 81 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.79705819 |
| 82 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.79127503 |
| 83 | primary alcohol catabolic process (GO:0034310) | 2.78711074 |
| 84 | hypotonic response (GO:0006971) | 2.77352584 |
| 85 | reverse cholesterol transport (GO:0043691) | 2.76664426 |
| 86 | regulation of cholesterol homeostasis (GO:2000188) | 2.76373941 |
| 87 | B cell homeostasis (GO:0001782) | 2.76166861 |
| 88 | regulation of natural killer cell differentiation (GO:0032823) | 2.75991867 |
| 89 | water homeostasis (GO:0030104) | 2.75546882 |
| 90 | drug transport (GO:0015893) | 2.74075059 |
| 91 | nitrogen cycle metabolic process (GO:0071941) | 2.73524025 |
| 92 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.72367443 |
| 93 | tyrosine metabolic process (GO:0006570) | 2.72247607 |
| 94 | peptide catabolic process (GO:0043171) | 2.72089625 |
| 95 | aromatic amino acid family metabolic process (GO:0009072) | 2.72067205 |
| 96 | linoleic acid metabolic process (GO:0043651) | 2.70211080 |
| 97 | macrophage activation involved in immune response (GO:0002281) | 2.69936025 |
| 98 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.68644527 |
| 99 | focal adhesion assembly (GO:0048041) | 2.67696607 |
| 100 | cell-substrate adherens junction assembly (GO:0007045) | 2.67696607 |
| 101 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.66987863 |
| 102 | imidazole-containing compound metabolic process (GO:0052803) | 2.66343877 |
| 103 | negative regulation of fibrinolysis (GO:0051918) | 2.64766554 |
| 104 | keratinization (GO:0031424) | 2.61867683 |
| 105 | fibrinolysis (GO:0042730) | 2.61554049 |
| 106 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.61528037 |
| 107 | glycosphingolipid catabolic process (GO:0046479) | 2.61217644 |
| 108 | ethanol oxidation (GO:0006069) | 2.60779918 |
| 109 | sodium-independent organic anion transport (GO:0043252) | 2.60185330 |
| 110 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.60094199 |
| 111 | alpha-amino acid catabolic process (GO:1901606) | 2.60025645 |
| 112 | positive regulation of sterol transport (GO:0032373) | 2.59605730 |
| 113 | positive regulation of cholesterol transport (GO:0032376) | 2.59605730 |
| 114 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.59113238 |
| 115 | benzene-containing compound metabolic process (GO:0042537) | 2.58391524 |
| 116 | regulation of fibrinolysis (GO:0051917) | 2.57901339 |
| 117 | positive regulation of Rap GTPase activity (GO:0032854) | 2.57386554 |
| 118 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.56589962 |
| 119 | cellular amino acid catabolic process (GO:0009063) | 2.56381750 |
| 120 | thioester biosynthetic process (GO:0035384) | 2.56202747 |
| 121 | acyl-CoA biosynthetic process (GO:0071616) | 2.56202747 |
| 122 | Golgi transport vesicle coating (GO:0048200) | 2.56048336 |
| 123 | COPI coating of Golgi vesicle (GO:0048205) | 2.56048336 |
| 124 | glutamate metabolic process (GO:0006536) | 2.55287142 |
| 125 | detection of bacterium (GO:0016045) | 2.55157703 |
| 126 | fatty acid oxidation (GO:0019395) | 2.53892209 |
| 127 | membrane raft organization (GO:0031579) | 2.53876592 |
| 128 | positive regulation of interferon-alpha production (GO:0032727) | 2.53679738 |
| 129 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.53504867 |
| 130 | hemidesmosome assembly (GO:0031581) | 2.53395702 |
| 131 | acylglycerol homeostasis (GO:0055090) | 2.52658495 |
| 132 | triglyceride homeostasis (GO:0070328) | 2.52658495 |
| 133 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.52568022 |
| 134 | negative regulation of sterol transport (GO:0032372) | 2.52080113 |
| 135 | negative regulation of cholesterol transport (GO:0032375) | 2.52080113 |
| 136 | bile acid and bile salt transport (GO:0015721) | 2.51637055 |
| 137 | cholesterol efflux (GO:0033344) | 2.51392150 |
| 138 | cortical actin cytoskeleton organization (GO:0030866) | 2.51069276 |
| 139 | skin morphogenesis (GO:0043589) | 2.50668944 |
| 140 | regulation of histone H3-K27 methylation (GO:0061085) | 2.50168199 |
| 141 | response to thyroid hormone (GO:0097066) | 2.49174632 |
| 142 | response to methylmercury (GO:0051597) | 2.48422568 |
| 143 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.47935236 |
| 144 | lipid oxidation (GO:0034440) | 2.47886897 |
| 145 | immunoglobulin mediated immune response (GO:0016064) | 2.47777380 |
| 146 | endocytic recycling (GO:0032456) | 2.47666675 |
| 147 | cellular glucuronidation (GO:0052695) | 2.47429081 |
| 148 | type I interferon signaling pathway (GO:0060337) | 2.47016942 |
| 149 | cellular response to type I interferon (GO:0071357) | 2.47016942 |
| 150 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.46398837 |
| 151 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.45321099 |
| 152 | surfactant homeostasis (GO:0043129) | 2.43496028 |
| 153 | COPII vesicle coating (GO:0048208) | 2.42676541 |
| 154 | positive regulation by symbiont of host defense response (GO:0052509) | 2.41622424 |
| 155 | modulation by symbiont of host defense response (GO:0052031) | 2.41622424 |
| 156 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.41622424 |
| 157 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.41622424 |
| 158 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.41622424 |
| 159 | modulation by symbiont of host immune response (GO:0052553) | 2.41622424 |
| 160 | positive regulation of macrophage cytokine production (GO:0060907) | 2.39876221 |
| 161 | response to type I interferon (GO:0034340) | 2.39674235 |
| 162 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.38945292 |
| 163 | adherens junction assembly (GO:0034333) | 2.37539582 |
| 164 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.36066060 |
| 165 | cellular response to ethanol (GO:0071361) | 2.35165147 |
| 166 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.34865497 |
| 167 | negative regulation of cell killing (GO:0031342) | 2.34865497 |
| 168 | nuclear pore organization (GO:0006999) | 2.34393537 |
| 169 | glycolipid catabolic process (GO:0019377) | 2.33460996 |
| 170 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.32623337 |
| 171 | regulation of interferon-alpha production (GO:0032647) | 2.32239676 |
| 172 | gland morphogenesis (GO:0022612) | 2.31624101 |
| 173 | positive regulation of protein oligomerization (GO:0032461) | 2.31314461 |
| 174 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.31224400 |
| 175 | negative regulation of anoikis (GO:2000811) | 2.29971955 |
| 176 | detection of molecule of bacterial origin (GO:0032490) | 2.28717899 |
| 177 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.28627757 |
| 178 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.27846697 |
| 179 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.27748361 |
| 180 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.27693013 |
| 181 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.27086362 |
| 182 | myeloid dendritic cell differentiation (GO:0043011) | 2.26611814 |
| 183 | barbed-end actin filament capping (GO:0051016) | 2.24156131 |
| 184 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.24149346 |
| 185 | mammary gland epithelial cell proliferation (GO:0033598) | 2.24141015 |
| 186 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.22909198 |
| 187 | pinocytosis (GO:0006907) | 2.22149953 |
| 188 | positive regulation of leukocyte degranulation (GO:0043302) | 2.21783539 |
| 189 | cellular response to arsenic-containing substance (GO:0071243) | 2.21638595 |
| 190 | vesicle coating (GO:0006901) | 2.19864210 |
| 191 | regulation of Rap GTPase activity (GO:0032317) | 2.19718872 |
| 192 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.18802478 |
| 193 | regulation of extracellular matrix disassembly (GO:0010715) | 2.18793109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.55558043 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.65501497 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.26557562 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.74790436 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.54275305 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.52225299 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.13259819 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.93532861 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.77161411 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.74382580 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.67045847 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.60273949 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.32472312 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.30419054 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.30006835 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.28717739 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.28463290 |
| 18 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.12187430 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02933264 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.02189249 |
| 21 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.99957537 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.99517078 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.86804261 |
| 24 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.78082180 |
| 25 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.77446185 |
| 26 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.72390402 |
| 27 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.71628702 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70795442 |
| 29 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.69826730 |
| 30 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.69442091 |
| 31 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.69407962 |
| 32 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.65660752 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.60570511 |
| 34 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.59059376 |
| 35 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.56673231 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.56070201 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55918668 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.54988782 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54451235 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53116543 |
| 41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52831031 |
| 42 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.51158328 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51103687 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.49791814 |
| 45 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.49330345 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48977856 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47362737 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45997394 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45690925 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45113884 |
| 51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44577395 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42937094 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42794556 |
| 54 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.37852922 |
| 55 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.36712897 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.32515480 |
| 57 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.32307798 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32004018 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31923217 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.31489109 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31372368 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.31018628 |
| 63 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.30767811 |
| 64 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.29411059 |
| 65 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29403691 |
| 66 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.29071521 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27906635 |
| 68 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.26568119 |
| 69 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.26539541 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25475709 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24995799 |
| 72 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.23249638 |
| 73 | MYB_26560356_Chip-Seq_TH2_Human | 1.21571828 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21487514 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21487514 |
| 76 | CJUN_26792858_Chip-Seq_BT549_Human | 1.21383604 |
| 77 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20204408 |
| 78 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.19933145 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19320481 |
| 80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18738861 |
| 81 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18660975 |
| 82 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18660975 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16988943 |
| 84 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.16654932 |
| 85 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.16607903 |
| 86 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15979414 |
| 87 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15692569 |
| 88 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.15503405 |
| 89 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.15441857 |
| 90 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.15212670 |
| 91 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.15104538 |
| 92 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.14957497 |
| 93 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.14718228 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13107548 |
| 95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11635045 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11321331 |
| 97 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10632120 |
| 98 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.10446115 |
| 99 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.09836344 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09232898 |
| 101 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08967453 |
| 102 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08266030 |
| 103 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.07809262 |
| 104 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07299635 |
| 105 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07125187 |
| 106 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07057321 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05734766 |
| 108 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05450402 |
| 109 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05360522 |
| 110 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03560752 |
| 111 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03312513 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03238376 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02822131 |
| 114 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01682023 |
| 115 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00993290 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00498347 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99746594 |
| 118 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.99698429 |
| 119 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99623335 |
| 120 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98898972 |
| 121 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.98708773 |
| 122 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98545110 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98244571 |
| 124 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97471239 |
| 125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97342008 |
| 126 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97149340 |
| 127 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.96452045 |
| 128 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96329396 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96130819 |
| 130 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96126732 |
| 131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.94827211 |
| 132 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.93995492 |
| 133 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93656643 |
| 134 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93302859 |
| 135 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.92773319 |
| 136 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.91906793 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89450112 |
| 138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88889677 |
| 139 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88735023 |
| 140 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85644959 |
| 141 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85415271 |
| 142 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85285404 |
| 143 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82857585 |
| 144 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.81613291 |
| 145 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.81398827 |
| 146 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.81398827 |
| 147 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80665761 |
| 148 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.80609177 |
| 149 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.76582151 |
| 150 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.76256584 |
| 151 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75632972 |
| 152 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.74815494 |
| 153 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.74220728 |
| 154 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.72508786 |
| 155 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71061738 |
| 156 | ATF3_27146783_Chip-Seq_COLON_Human | 0.70471909 |
| 157 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.69920696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 4.73086523 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.78928482 |
| 3 | MP0002796_impaired_skin_barrier | 3.76265851 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.70334918 |
| 5 | MP0005360_urolithiasis | 3.50025518 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 2.83600175 |
| 7 | MP0003195_calcinosis | 2.81149288 |
| 8 | MP0005365_abnormal_bile_salt | 2.80872048 |
| 9 | MP0004381_abnormal_hair_follicle | 2.49080521 |
| 10 | MP0005275_abnormal_skin_tensile | 2.48186706 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.44227248 |
| 12 | MP0005451_abnormal_body_composition | 2.39102615 |
| 13 | MP0003091_abnormal_cell_migration | 2.36768693 |
| 14 | MP0008057_abnormal_DNA_replication | 2.32124879 |
| 15 | MP0010678_abnormal_skin_adnexa | 2.22517285 |
| 16 | MP0003303_peritoneal_inflammation | 2.21991274 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.13933704 |
| 18 | MP0003252_abnormal_bile_duct | 2.11137217 |
| 19 | MP0002060_abnormal_skin_morphology | 2.06244584 |
| 20 | MP0005501_abnormal_skin_physiology | 2.03756568 |
| 21 | MP0004947_skin_inflammation | 2.00507737 |
| 22 | MP0003453_abnormal_keratinocyte_physiol | 2.00245097 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.97736572 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.94633130 |
| 25 | MP0001666_abnormal_nutrient_absorption | 1.91486990 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.90790173 |
| 27 | MP0001216_abnormal_epidermal_layer | 1.88563250 |
| 28 | MP0000383_abnormal_hair_follicle | 1.86637427 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.86608874 |
| 30 | MP0001800_abnormal_humoral_immune | 1.79734023 |
| 31 | MP0001346_abnormal_lacrimal_gland | 1.78256135 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.77642448 |
| 33 | MP0000579_abnormal_nail_morphology | 1.77625507 |
| 34 | MP0002009_preneoplasia | 1.76044494 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.74683849 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.70619979 |
| 37 | MP0005332_abnormal_amino_acid | 1.68070920 |
| 38 | MP0009840_abnormal_foam_cell | 1.64141466 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.62319732 |
| 40 | MP0000377_abnormal_hair_follicle | 1.61052186 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.59429503 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.58641053 |
| 43 | MP0010329_abnormal_lipoprotein_level | 1.57350210 |
| 44 | MP0002098_abnormal_vibrissa_morphology | 1.56213223 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.52801594 |
| 46 | MP0009643_abnormal_urine_homeostasis | 1.50555650 |
| 47 | MP0008260_abnormal_autophagy | 1.48695130 |
| 48 | MP0005310_abnormal_salivary_gland | 1.48143347 |
| 49 | MP0010386_abnormal_urinary_bladder | 1.44927067 |
| 50 | MP0010771_integument_phenotype | 1.43935595 |
| 51 | MP0005623_abnormal_meninges_morphology | 1.42917428 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.41852539 |
| 53 | MP0000647_abnormal_sebaceous_gland | 1.37501388 |
| 54 | MP0002723_abnormal_immune_serum | 1.37421299 |
| 55 | MP0001873_stomach_inflammation | 1.36439956 |
| 56 | MP0005023_abnormal_wound_healing | 1.33192395 |
| 57 | MP0001851_eye_inflammation | 1.32796592 |
| 58 | MP0009384_cardiac_valve_regurgitation | 1.31966746 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.31316385 |
| 60 | MP0000685_abnormal_immune_system | 1.29973090 |
| 61 | MP0000858_altered_metastatic_potential | 1.29251161 |
| 62 | MP0000609_abnormal_liver_physiology | 1.28742322 |
| 63 | MP0000427_abnormal_hair_cycle | 1.28331300 |
| 64 | MP0001819_abnormal_immune_cell | 1.28026033 |
| 65 | MP0002419_abnormal_innate_immunity | 1.27254261 |
| 66 | MP0002118_abnormal_lipid_homeostasis | 1.25560189 |
| 67 | MP0005647_abnormal_sex_gland | 1.23122351 |
| 68 | MP0003941_abnormal_skin_development | 1.23081469 |
| 69 | MP0001765_abnormal_ion_homeostasis | 1.20385256 |
| 70 | MP0000604_amyloidosis | 1.18613635 |
| 71 | MP0005621_abnormal_cell_physiology | 1.16865040 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 1.16610393 |
| 73 | MP0001853_heart_inflammation | 1.15249386 |
| 74 | MP0003183_abnormal_peptide_metabolism | 1.14544106 |
| 75 | MP0005083_abnormal_biliary_tract | 1.14416127 |
| 76 | MP0003436_decreased_susceptibility_to | 1.12382778 |
| 77 | MP0003448_altered_tumor_morphology | 1.11956389 |
| 78 | MP0005025_abnormal_response_to | 1.11189204 |
| 79 | MP0002398_abnormal_bone_marrow | 1.10592469 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.08788115 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 1.06296806 |
| 82 | MP0000716_abnormal_immune_system | 1.04641505 |
| 83 | MP0004264_abnormal_extraembryonic_tissu | 1.04635607 |
| 84 | MP0003279_aneurysm | 1.04018179 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 1.03503088 |
| 86 | MP0003690_abnormal_glial_cell | 1.03350236 |
| 87 | MP0001756_abnormal_urination | 1.02848593 |
| 88 | MP0004043_abnormal_pH_regulation | 1.01243607 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 1.00899565 |
| 90 | MP0002148_abnormal_hypersensitivity_rea | 1.00837994 |
| 91 | MP0009785_altered_susceptibility_to | 1.00441731 |
| 92 | MP0001958_emphysema | 1.00043230 |
| 93 | MP0002006_tumorigenesis | 0.98806610 |
| 94 | MP0005671_abnormal_response_to | 0.98757336 |
| 95 | MP0005464_abnormal_platelet_physiology | 0.98170750 |
| 96 | MP0002405_respiratory_system_inflammati | 0.97651404 |
| 97 | MP0005220_abnormal_exocrine_pancreas | 0.97095361 |
| 98 | MP0002396_abnormal_hematopoietic_system | 0.95939834 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.95030908 |
| 100 | MP0000538_abnormal_urinary_bladder | 0.94278377 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.93791054 |
| 102 | MP0010307_abnormal_tumor_latency | 0.93588565 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.93573353 |
| 104 | MP0000689_abnormal_spleen_morphology | 0.93021202 |
| 105 | MP0006082_CNS_inflammation | 0.92191637 |
| 106 | MP0010352_gastrointestinal_tract_polyps | 0.91217866 |
| 107 | MP0008004_abnormal_stomach_pH | 0.90603691 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.90370698 |
| 109 | MP0009931_abnormal_skin_appearance | 0.90250179 |
| 110 | MP0001191_abnormal_skin_condition | 0.89600783 |
| 111 | MP0002429_abnormal_blood_cell | 0.88754971 |
| 112 | MP0003329_amyloid_beta_deposits | 0.87088009 |
| 113 | MP0000367_abnormal_coat/_hair | 0.86914734 |
| 114 | MP0001835_abnormal_antigen_presentation | 0.86723372 |
| 115 | MP0000537_abnormal_urethra_morphology | 0.86498004 |
| 116 | MP0003868_abnormal_feces_composition | 0.86477705 |
| 117 | MP0003828_pulmonary_edema | 0.86321423 |
| 118 | MP0003075_altered_response_to | 0.85879136 |
| 119 | MP0005409_darkened_coat_color | 0.85172818 |
| 120 | MP0003806_abnormal_nucleotide_metabolis | 0.84961852 |
| 121 | MP0002722_abnormal_immune_system | 0.84798082 |
| 122 | MP0001533_abnormal_skeleton_physiology | 0.83186948 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.82883340 |
| 124 | MP0003566_abnormal_cell_adhesion | 0.82302649 |
| 125 | MP0005164_abnormal_response_to | 0.81439388 |
| 126 | MP0003045_fibrosis | 0.81278735 |
| 127 | MP0004272_abnormal_basement_membrane | 0.81146242 |
| 128 | MP0001243_abnormal_dermal_layer | 0.81009727 |
| 129 | MP0000465_gastrointestinal_hemorrhage | 0.79686871 |
| 130 | MP0000920_abnormal_myelination | 0.78928276 |
| 131 | MP0000003_abnormal_adipose_tissue | 0.78865202 |
| 132 | MP0009764_decreased_sensitivity_to | 0.78524446 |
| 133 | MP0005408_hypopigmentation | 0.77951289 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76876383 |
| 135 | MP0005166_decreased_susceptibility_to | 0.76678922 |
| 136 | MP0000467_abnormal_esophagus_morphology | 0.76356279 |
| 137 | MP0008469_abnormal_protein_level | 0.75914411 |
| 138 | MP0004510_myositis | 0.75017111 |
| 139 | MP0000627_abnormal_mammary_gland | 0.74550055 |
| 140 | MP0000613_abnormal_salivary_gland | 0.74522633 |
| 141 | MP0005257_abnormal_intraocular_pressure | 0.74028461 |
| 142 | MP0005384_cellular_phenotype | 0.73948940 |
| 143 | MP0001845_abnormal_inflammatory_respons | 0.73553447 |
| 144 | MP0001881_abnormal_mammary_gland | 0.73260417 |
| 145 | MP0001790_abnormal_immune_system | 0.73109873 |
| 146 | MP0005387_immune_system_phenotype | 0.73109873 |
| 147 | MP0001764_abnormal_homeostasis | 0.72889882 |
| 148 | MP0003638_abnormal_response/metabolism_ | 0.70739379 |
| 149 | MP0003011_delayed_dark_adaptation | 0.70207969 |
| 150 | MP0006054_spinal_hemorrhage | 0.69260334 |
| 151 | MP0002896_abnormal_bone_mineralization | 0.68660768 |
| 152 | MP0008438_abnormal_cutaneous_collagen | 0.64788868 |
| 153 | MP0010155_abnormal_intestine_physiology | 0.64463047 |
| 154 | MP0001348_abnormal_lacrimal_gland | 0.63559056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 4.08232221 |
| 2 | Xanthomatosis (HP:0000991) | 3.98873881 |
| 3 | Gastrointestinal stroma tumor (HP:0100723) | 3.90415726 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.77894128 |
| 5 | Deep venous thrombosis (HP:0002625) | 3.66628868 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 3.62404104 |
| 7 | Complement deficiency (HP:0004431) | 3.49377404 |
| 8 | Cellulitis (HP:0100658) | 3.28994112 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.24121447 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 3.22519512 |
| 11 | Increased IgE level (HP:0003212) | 3.19111217 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 3.18370240 |
| 13 | Lip pit (HP:0100267) | 3.07266959 |
| 14 | Plantar hyperkeratosis (HP:0007556) | 2.98885802 |
| 15 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.96098328 |
| 16 | Subacute progressive viral hepatitis (HP:0006572) | 2.90104863 |
| 17 | Palmoplantar hyperkeratosis (HP:0000972) | 2.89916181 |
| 18 | Dysostosis multiplex (HP:0000943) | 2.88656686 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.87940250 |
| 20 | Epidermoid cyst (HP:0200040) | 2.86727335 |
| 21 | Fat malabsorption (HP:0002630) | 2.85367036 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 2.83770489 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 2.79430682 |
| 24 | Abnormality of the axillary hair (HP:0100134) | 2.74474742 |
| 25 | Abnormality of secondary sexual hair (HP:0009888) | 2.74474742 |
| 26 | Hyperglycinemia (HP:0002154) | 2.74048305 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 2.72470910 |
| 28 | Ketosis (HP:0001946) | 2.72390316 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.71664242 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 2.71664242 |
| 31 | Viral hepatitis (HP:0006562) | 2.71310533 |
| 32 | Abnormality of complement system (HP:0005339) | 2.71189609 |
| 33 | Hyperglycinuria (HP:0003108) | 2.69714897 |
| 34 | Colitis (HP:0002583) | 2.69294997 |
| 35 | Osteomyelitis (HP:0002754) | 2.64839974 |
| 36 | Abnormality of glycolipid metabolism (HP:0010969) | 2.63506587 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.63506587 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.63506587 |
| 39 | Parakeratosis (HP:0001036) | 2.63022867 |
| 40 | Eczematoid dermatitis (HP:0000976) | 2.60280860 |
| 41 | Hypoglycemic coma (HP:0001325) | 2.58965462 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.58660648 |
| 43 | Vertebral compression fractures (HP:0002953) | 2.57707500 |
| 44 | Palmar hyperkeratosis (HP:0010765) | 2.56613351 |
| 45 | Agammaglobulinemia (HP:0004432) | 2.56516371 |
| 46 | Emphysema (HP:0002097) | 2.55028588 |
| 47 | Abnormality of the intrinsic pathway (HP:0010989) | 2.54494008 |
| 48 | Arterial tortuosity (HP:0005116) | 2.52387751 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.52020294 |
| 50 | Myocardial infarction (HP:0001658) | 2.51848444 |
| 51 | Hypotrichosis (HP:0001006) | 2.51397144 |
| 52 | Mucopolysacchariduria (HP:0008155) | 2.50763549 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.50763549 |
| 54 | Hypobetalipoproteinemia (HP:0003563) | 2.48512767 |
| 55 | Recurrent bacterial skin infections (HP:0005406) | 2.47461515 |
| 56 | Woolly hair (HP:0002224) | 2.46192065 |
| 57 | Gout (HP:0001997) | 2.46110830 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.45251329 |
| 59 | Recurrent viral infections (HP:0004429) | 2.43016640 |
| 60 | Onycholysis (HP:0001806) | 2.41428181 |
| 61 | Ketoacidosis (HP:0001993) | 2.39618225 |
| 62 | Abnormality of nail color (HP:0100643) | 2.38720025 |
| 63 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.37260084 |
| 64 | Type I diabetes mellitus (HP:0100651) | 2.36801898 |
| 65 | Vascular tortuosity (HP:0004948) | 2.33561007 |
| 66 | Steatorrhea (HP:0002570) | 2.32155302 |
| 67 | Recurrent abscess formation (HP:0002722) | 2.30177807 |
| 68 | Atrophic scars (HP:0001075) | 2.30136587 |
| 69 | Joint hemorrhage (HP:0005261) | 2.29502896 |
| 70 | Erythroderma (HP:0001019) | 2.26394012 |
| 71 | Hyperammonemia (HP:0001987) | 2.24495026 |
| 72 | Neurofibrillary tangles (HP:0002185) | 2.22164294 |
| 73 | Vascular calcification (HP:0004934) | 2.21420199 |
| 74 | Protuberant abdomen (HP:0001538) | 2.21174087 |
| 75 | Hydroxyprolinuria (HP:0003080) | 2.21158984 |
| 76 | Abnormality of proline metabolism (HP:0010907) | 2.21158984 |
| 77 | Lower limb hyperreflexia (HP:0002395) | 2.19522517 |
| 78 | Conjugated hyperbilirubinemia (HP:0002908) | 2.18915964 |
| 79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18228519 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18228519 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18228519 |
| 82 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.17737408 |
| 83 | Hypokalemic alkalosis (HP:0001949) | 2.16752493 |
| 84 | Glomerulonephritis (HP:0000099) | 2.15117807 |
| 85 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.11536359 |
| 86 | Osteolytic defects of the hand bones (HP:0009699) | 2.11536359 |
| 87 | Tetraparesis (HP:0002273) | 2.11354400 |
| 88 | Premature rupture of membranes (HP:0001788) | 2.09360873 |
| 89 | Erythema (HP:0010783) | 2.09173895 |
| 90 | Slow saccadic eye movements (HP:0000514) | 2.08926200 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.08003860 |
| 92 | Axonal loss (HP:0003447) | 2.07360320 |
| 93 | Protrusio acetabuli (HP:0003179) | 2.06214423 |
| 94 | Sensory axonal neuropathy (HP:0003390) | 2.06171827 |
| 95 | Flat acetabular roof (HP:0003180) | 2.05198658 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 2.04457073 |
| 97 | Hypolipoproteinemia (HP:0010981) | 2.02982524 |
| 98 | Pancreatitis (HP:0001733) | 2.00022034 |
| 99 | Hypoplasia of the uterus (HP:0000013) | 1.99737981 |
| 100 | Meningitis (HP:0001287) | 1.98289852 |
| 101 | Hyperglycemia (HP:0003074) | 1.98092426 |
| 102 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.97452877 |
| 103 | Hypoalphalipoproteinemia (HP:0003233) | 1.96344731 |
| 104 | Abnormality of chloride homeostasis (HP:0011422) | 1.96033311 |
| 105 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.95078115 |
| 106 | Recurrent bronchitis (HP:0002837) | 1.92978765 |
| 107 | Inflammation of the large intestine (HP:0002037) | 1.92747031 |
| 108 | Termporal pattern (HP:0011008) | 1.92420287 |
| 109 | Insidious onset (HP:0003587) | 1.92420287 |
| 110 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.91841731 |
| 111 | Upper motor neuron abnormality (HP:0002127) | 1.90457175 |
| 112 | Thick nail (HP:0001805) | 1.90447482 |
| 113 | IgA deficiency (HP:0002720) | 1.90397114 |
| 114 | Rickets (HP:0002748) | 1.90031183 |
| 115 | Micronodular cirrhosis (HP:0001413) | 1.89603270 |
| 116 | Restrictive lung disease (HP:0002091) | 1.88755159 |
| 117 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.88642842 |
| 118 | Asymmetry of the thorax (HP:0001555) | 1.88616848 |
| 119 | Hyporeflexia of lower limbs (HP:0002600) | 1.87384692 |
| 120 | Conjunctival hamartoma (HP:0100780) | 1.86303905 |
| 121 | Gingivitis (HP:0000230) | 1.86246788 |
| 122 | Generalized aminoaciduria (HP:0002909) | 1.82391360 |
| 123 | Elevated alkaline phosphatase (HP:0003155) | 1.82330434 |
| 124 | Spinal cord lesions (HP:0100561) | 1.81933728 |
| 125 | Syringomyelia (HP:0003396) | 1.81933728 |
| 126 | Pili torti (HP:0003777) | 1.81495578 |
| 127 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81074806 |
| 128 | Natal tooth (HP:0000695) | 1.80979196 |
| 129 | Abnormal tarsal ossification (HP:0008369) | 1.80526037 |
| 130 | Chronic diarrhea (HP:0002028) | 1.80500280 |
| 131 | Ankyloglossia (HP:0010296) | 1.79920628 |
| 132 | Hepatitis (HP:0012115) | 1.79831676 |
| 133 | Abnormality of nucleobase metabolism (HP:0010932) | 1.79718244 |
| 134 | Fragile nails (HP:0001808) | 1.79655582 |
| 135 | Abnormality of the gastric mucosa (HP:0004295) | 1.78688279 |
| 136 | Papilloma (HP:0012740) | 1.77582623 |
| 137 | Verrucae (HP:0200043) | 1.77582623 |
| 138 | Nephritis (HP:0000123) | 1.77568652 |
| 139 | Hypophosphatemic rickets (HP:0004912) | 1.77026452 |
| 140 | Hypoglycemic seizures (HP:0002173) | 1.76585200 |
| 141 | Vasculitis (HP:0002633) | 1.76201806 |
| 142 | Malnutrition (HP:0004395) | 1.76142355 |
| 143 | Recurrent skin infections (HP:0001581) | 1.75647631 |
| 144 | Abnormal hemoglobin (HP:0011902) | 1.75220635 |
| 145 | Abnormal foot bone ossification (HP:0010675) | 1.73557564 |
| 146 | Cerebral inclusion bodies (HP:0100314) | 1.73052356 |
| 147 | Pustule (HP:0200039) | 1.73042569 |
| 148 | Anhidrosis (HP:0000970) | 1.72976704 |
| 149 | Spontaneous hematomas (HP:0007420) | 1.72787447 |
| 150 | Coarse hair (HP:0002208) | 1.72160176 |
| 151 | Bone pain (HP:0002653) | 1.71874683 |
| 152 | Spinal cord compression (HP:0002176) | 1.71004302 |
| 153 | Interstitial pulmonary disease (HP:0006530) | 1.70714977 |
| 154 | Insomnia (HP:0100785) | 1.70263626 |
| 155 | Apathy (HP:0000741) | 1.68620037 |
| 156 | Premature loss of primary teeth (HP:0006323) | 1.68082310 |
| 157 | Scanning speech (HP:0002168) | 1.67582788 |
| 158 | Ankle contracture (HP:0006466) | 1.67031958 |
| 159 | Ridged nail (HP:0001807) | 1.66318082 |
| 160 | Lymphopenia (HP:0001888) | 1.65999642 |
| 161 | Mitral stenosis (HP:0001718) | 1.61678382 |
| 162 | Global brain atrophy (HP:0002283) | 1.61527605 |
| 163 | Bladder carcinoma (HP:0002862) | 1.60922285 |
| 164 | Bladder neoplasm (HP:0009725) | 1.60922285 |
| 165 | Alopecia of scalp (HP:0002293) | 1.59882979 |
| 166 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.59869107 |
| 167 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.59865466 |
| 168 | Overlapping toe (HP:0001845) | 1.59388678 |
| 169 | Fragile skin (HP:0001030) | 1.58859306 |
| 170 | Diminished motivation (HP:0000745) | 1.58848911 |
| 171 | Disinhibition (HP:0000734) | 1.58795664 |
| 172 | Periodontitis (HP:0000704) | 1.57344884 |
| 173 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.57233170 |
| 174 | Milia (HP:0001056) | 1.57026068 |
| 175 | Fatigue (HP:0012378) | 1.55088217 |
| 176 | Dilatation of the ascending aorta (HP:0005111) | 1.54459642 |
| 177 | Supranuclear gaze palsy (HP:0000605) | 1.54361584 |
| 178 | Leiomyosarcoma (HP:0100243) | 1.53511394 |
| 179 | Uterine leiomyosarcoma (HP:0002891) | 1.53511394 |
| 180 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.53104855 |
| 181 | Thin bony cortex (HP:0002753) | 1.52489236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.57922496 |
| 2 | ERN1 | 3.27690965 |
| 3 | STK39 | 3.06182968 |
| 4 | FRK | 2.89298167 |
| 5 | MST1R | 2.85067289 |
| 6 | TAOK3 | 2.80287605 |
| 7 | MAP3K13 | 2.75921818 |
| 8 | EPHB1 | 2.67272759 |
| 9 | MAP3K9 | 2.55201559 |
| 10 | MST4 | 2.53289869 |
| 11 | FGFR4 | 2.43627820 |
| 12 | BCKDK | 2.40936855 |
| 13 | WNK4 | 2.32475129 |
| 14 | MAP3K2 | 2.29617483 |
| 15 | LATS1 | 2.20031319 |
| 16 | MAP3K3 | 2.15930933 |
| 17 | FER | 1.99495830 |
| 18 | PIK3CG | 1.96728392 |
| 19 | TYK2 | 1.94991191 |
| 20 | OXSR1 | 1.93510058 |
| 21 | CDK12 | 1.90723355 |
| 22 | EPHA3 | 1.90142446 |
| 23 | TRIB3 | 1.86058192 |
| 24 | LATS2 | 1.85522018 |
| 25 | SMG1 | 1.85291235 |
| 26 | BMPR2 | 1.85177527 |
| 27 | PTK6 | 1.83536889 |
| 28 | ARAF | 1.64671950 |
| 29 | MAP3K14 | 1.64243707 |
| 30 | TNK2 | 1.62950813 |
| 31 | INSRR | 1.61890027 |
| 32 | MAPKAPK5 | 1.58624976 |
| 33 | MAP4K1 | 1.58561999 |
| 34 | IRAK3 | 1.57550689 |
| 35 | LRRK2 | 1.56229458 |
| 36 | SIK1 | 1.56088614 |
| 37 | CAMKK2 | 1.53232536 |
| 38 | MAPK15 | 1.49394234 |
| 39 | KSR2 | 1.46635332 |
| 40 | ICK | 1.40300857 |
| 41 | NLK | 1.37601859 |
| 42 | CSF1R | 1.32310594 |
| 43 | JAK1 | 1.31259633 |
| 44 | MAPKAPK3 | 1.27858998 |
| 45 | TRPM7 | 1.26457053 |
| 46 | PKN2 | 1.25716790 |
| 47 | JAK2 | 1.18776376 |
| 48 | ITK | 1.16995203 |
| 49 | MET | 1.13174338 |
| 50 | FGFR3 | 1.07782219 |
| 51 | MAP3K1 | 1.07243930 |
| 52 | FGFR2 | 1.06395729 |
| 53 | MELK | 1.04594681 |
| 54 | SIK3 | 0.99932482 |
| 55 | TBK1 | 0.99439091 |
| 56 | SCYL2 | 0.97695556 |
| 57 | STK10 | 0.96852302 |
| 58 | EPHA2 | 0.94929452 |
| 59 | MOS | 0.93741714 |
| 60 | EEF2K | 0.90555785 |
| 61 | DYRK1B | 0.90313150 |
| 62 | AKT3 | 0.88760948 |
| 63 | MAP3K8 | 0.88137126 |
| 64 | BRAF | 0.88097737 |
| 65 | IRAK1 | 0.87886997 |
| 66 | STK3 | 0.85515524 |
| 67 | CAMKK1 | 0.85070257 |
| 68 | TAOK2 | 0.84961648 |
| 69 | TGFBR2 | 0.84211963 |
| 70 | MAP2K2 | 0.84136173 |
| 71 | HIPK2 | 0.84097132 |
| 72 | WNK1 | 0.81256360 |
| 73 | STK24 | 0.78479442 |
| 74 | SGK3 | 0.75644701 |
| 75 | GSK3A | 0.75202919 |
| 76 | MAP3K12 | 0.74849444 |
| 77 | PRKAA2 | 0.74308017 |
| 78 | RET | 0.72826419 |
| 79 | MAP3K7 | 0.72639559 |
| 80 | PAK4 | 0.69937510 |
| 81 | NEK9 | 0.68801590 |
| 82 | JAK3 | 0.67973144 |
| 83 | TTN | 0.65724898 |
| 84 | BRD4 | 0.65377225 |
| 85 | BLK | 0.65268391 |
| 86 | EIF2AK3 | 0.65028012 |
| 87 | MAP2K3 | 0.64360519 |
| 88 | BTK | 0.63762056 |
| 89 | TEC | 0.62933620 |
| 90 | IKBKE | 0.59970845 |
| 91 | RIPK4 | 0.59830388 |
| 92 | YES1 | 0.59630358 |
| 93 | RAF1 | 0.59333054 |
| 94 | CAMK1D | 0.58534530 |
| 95 | PTK2 | 0.57793549 |
| 96 | IRAK2 | 0.56162052 |
| 97 | BMPR1B | 0.55032138 |
| 98 | KSR1 | 0.54138255 |
| 99 | CDK4 | 0.54126527 |
| 100 | MAPK12 | 0.53527946 |
| 101 | ERBB3 | 0.53077980 |
| 102 | PAK2 | 0.51654470 |
| 103 | NME2 | 0.51168721 |
| 104 | SYK | 0.50672493 |
| 105 | TAOK1 | 0.50531450 |
| 106 | STK4 | 0.49985050 |
| 107 | IRAK4 | 0.48738289 |
| 108 | MAPK7 | 0.48707420 |
| 109 | PDGFRA | 0.48641385 |
| 110 | CSK | 0.48279084 |
| 111 | DMPK | 0.47852102 |
| 112 | WNK3 | 0.47707941 |
| 113 | RIPK1 | 0.46349762 |
| 114 | MTOR | 0.46106399 |
| 115 | FGR | 0.45865462 |
| 116 | PDPK1 | 0.45725233 |
| 117 | PRKD1 | 0.45261436 |
| 118 | EGFR | 0.44823209 |
| 119 | RPS6KA4 | 0.44413136 |
| 120 | TESK1 | 0.44318492 |
| 121 | CDC42BPA | 0.43067402 |
| 122 | NTRK1 | 0.42839988 |
| 123 | CDK6 | 0.42289148 |
| 124 | PDK2 | 0.42202173 |
| 125 | PAK3 | 0.41906977 |
| 126 | ALK | 0.41824956 |
| 127 | PRKCQ | 0.41655161 |
| 128 | RPS6KB2 | 0.41440083 |
| 129 | CLK1 | 0.40801378 |
| 130 | MAP2K1 | 0.40323263 |
| 131 | GRK1 | 0.39952583 |
| 132 | EIF2AK1 | 0.38469877 |
| 133 | MAPK11 | 0.38337352 |
| 134 | PDK1 | 0.37817052 |
| 135 | FLT3 | 0.35362155 |
| 136 | ERBB4 | 0.35187001 |
| 137 | IKBKB | 0.35153642 |
| 138 | ZAP70 | 0.34968704 |
| 139 | PDGFRB | 0.34777686 |
| 140 | IGF1R | 0.34743188 |
| 141 | ERBB2 | 0.34712652 |
| 142 | MAP2K4 | 0.33540034 |
| 143 | MAPK4 | 0.33415276 |
| 144 | CAMK1G | 0.30777533 |
| 145 | RPS6KB1 | 0.30374988 |
| 146 | MAPKAPK2 | 0.30241040 |
| 147 | MAP3K10 | 0.29914050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.04922841 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.02516027 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.88254387 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.59430500 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 2.52812755 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.39262250 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.30001357 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.15016280 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.06698957 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.01764613 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.99616142 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.98610015 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.97940807 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.96320397 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.95250931 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.89809610 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88041046 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.86777281 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.79602201 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79483952 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.74081624 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.72575267 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70993174 |
| 24 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.68739075 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.68019425 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.66967649 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.66268195 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.61540400 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60913617 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59032976 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58115050 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57178293 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55038723 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.53265341 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.52402741 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.50856773 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.49775826 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.49272668 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.49236276 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46532912 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.45580458 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 1.44005138 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.42709210 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.42328126 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.42143480 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.39310207 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39076523 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39029349 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.38932395 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.37745130 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.35829649 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34858423 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.30965924 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.30369210 |
| 55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.29578697 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28785138 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27613489 |
| 58 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26923485 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.23472105 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23286106 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 1.21857147 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20263225 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20114552 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 1.20015708 |
| 65 | Endometrial cancer_Homo sapiens_hsa05213 | 1.18861471 |
| 66 | Asthma_Homo sapiens_hsa05310 | 1.16182569 |
| 67 | Measles_Homo sapiens_hsa05162 | 1.14858291 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.12802680 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11923840 |
| 70 | Bile secretion_Homo sapiens_hsa04976 | 1.11797593 |
| 71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.11712694 |
| 72 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10247572 |
| 73 | Long-term potentiation_Homo sapiens_hsa04720 | 1.09884109 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 1.09712726 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.06975699 |
| 76 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.06837232 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 1.04622596 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 1.04288746 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.03370171 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.03114143 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02476966 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02396031 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.01820203 |
| 84 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.01012294 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00974232 |
| 86 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00015007 |
| 87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99973724 |
| 88 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99788214 |
| 89 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99148627 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.98263129 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.97615473 |
| 92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.97442218 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.96955044 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95578656 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94956170 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92381038 |
| 97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90964400 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90842295 |
| 99 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90355729 |
| 100 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90342274 |
| 101 | Focal adhesion_Homo sapiens_hsa04510 | 0.88725291 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86425256 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86161690 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85414245 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.85046771 |
| 106 | Alcoholism_Homo sapiens_hsa05034 | 0.83381521 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81042529 |
| 108 | Protein export_Homo sapiens_hsa03060 | 0.80880292 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80079617 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79918182 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78388123 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77455080 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76965623 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.75738459 |
| 115 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74995402 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73451962 |
| 117 | Shigellosis_Homo sapiens_hsa05131 | 0.73382996 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72797329 |
| 119 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72729347 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71511625 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71500304 |
| 122 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70098340 |
| 123 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69438148 |
| 124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69399089 |
| 125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68437510 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68186323 |
| 127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68123293 |
| 128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67237237 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66532246 |
| 130 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66502133 |
| 131 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.66331832 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.65881473 |
| 133 | Platelet activation_Homo sapiens_hsa04611 | 0.65345056 |
| 134 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65116342 |
| 135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64254012 |
| 136 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63506293 |
| 137 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62440315 |
| 138 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59750543 |
| 139 | Insulin resistance_Homo sapiens_hsa04931 | 0.59354391 |
| 140 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57860407 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56084730 |
| 142 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54554718 |
| 143 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53673361 |
| 144 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52456982 |
| 145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49638989 |
| 146 | Legionellosis_Homo sapiens_hsa05134 | 0.49503770 |
| 147 | Salmonella infection_Homo sapiens_hsa05132 | 0.47648667 |
| 148 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45807322 |
| 149 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.45056833 |
| 150 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43828545 |
| 151 | Amoebiasis_Homo sapiens_hsa05146 | 0.43367443 |
| 152 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40389161 |
| 153 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38415713 |
| 154 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36716714 |
| 155 | Hepatitis C_Homo sapiens_hsa05160 | 0.36615356 |
| 156 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35982215 |
| 157 | Pertussis_Homo sapiens_hsa05133 | 0.35650715 |
| 158 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.35558718 |
| 159 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.34880218 |
| 160 | Lysine degradation_Homo sapiens_hsa00310 | 0.34315707 |
| 161 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32293119 |
| 162 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31398437 |
| 163 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.30855507 |
| 164 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28459458 |
| 165 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.25448030 |
| 166 | Mineral absorption_Homo sapiens_hsa04978 | 0.25279115 |
| 167 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25174867 |
| 168 | Carbon metabolism_Homo sapiens_hsa01200 | 0.24857653 |
| 169 | Prion diseases_Homo sapiens_hsa05020 | 0.24631747 |
| 170 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23658894 |
| 171 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.22885262 |
| 172 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22223489 |
| 173 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.21534991 |
| 174 | Prostate cancer_Homo sapiens_hsa05215 | 0.21332792 |
| 175 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20780536 |
| 176 | Leishmaniasis_Homo sapiens_hsa05140 | 0.20275488 |
| 177 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.19186582 |
| 178 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.18693820 |

